Approval · Notice of Compliance 8917 · 2007
METHOTREXATE TABLETS, USP: Notice of Compliance 8917
Issued July 18, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8917
- Date
- July 18, 2007
- Company
- Hospira Healthcare CorporationKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Antimetabolite and antirheumatic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METHOTREXATE TABLETS, USP | 02182750 | Marketed |
Medicinal ingredients
- METHOTREXATE 10 MG per TAB